《盈警響號》新興光學(00125.HK)料全年盈轉虧 蝕最多3,500萬元
新興光學(00125.HK)發盈警,預期截至今年3月底止年度將可能錄得應佔虧損約3,000萬元至3,500萬元,對比2022年同期則錄得應佔溢利約900萬元。
集團指,全年盈轉虧主要是由於評估未來嚴俊的及不明朗的商業環境對集團眼鏡產品製造及貿易業務之影響後,預期集團的已識別長期資產將錄得非現金減值虧損約2,500萬元;及集團於截至2023年3月底止年度之營業額對比去年同期錄得約20%跌幅,此等造成的負面經濟規模效應導致集團的盈利能力下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.